Tesla, Inc. vs Novartis AG
Tesla, Inc. is worth $1.366T, 4.6× the $299.439B market cap of Novartis AG. Updated daily.
| Metric | Tesla, Inc.TSLA ![]() | Novartis AGNVS ![]() |
|---|---|---|
| Market cap | $1.366T | $299.439B |
| Global rank | #1 | #2 |
| Share price | $345.82 | $157.54 |
| Change | +3.91% | +1.90% |
| Revenue | $94.827B | $56.674B |
| Net income | $3.794B | $13.984B |
| Country | United States | Switzerland |
| Sector | Consumer Cyclical | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Tesla, Inc. bigger than Novartis AG?
- Tesla, Inc. has a market cap of $1.366T against $299.439B for Novartis AG, making it 4.6 times as valuable.
- Which company earns more, TSLA or NVS?
- Tesla, Inc. reported net income of $3.794B and Novartis AG reported $13.984B in their most recent annual periods.

